Value of serum copeptin in the early diagnosis and short-termprognosis of acute myocardial infarction

ZHU Chenying,CAI Ying,ZI Haijing,YU Ping,ZHUANG Shaowei,LIU Xuebo
DOI: https://doi.org/10.13201/j.issn.1001-1439.2013.05.016
2013-01-01
Journal of Clinical Cardiology
Abstract:Objective:To investigate the value of serum copeptin in the early diagnosis and short-term prognosis of acute myocardial infarction(AMI). Method:Ninety-two AMI patients with chest pain were recruited.The serum levels of copeptin and high sensitivity troponin T(hs-TnT) were detected in all patients within 3 h,6 h,12 h,and 24 h after onset of the chest pain.The major adverse cardiovascular events(MACE) were recorded during the follow-up of 12 months. Result:The copeptin level in AMI patients within 3 hours after the onset of pain was significantly higher than that in the normal control(P<0.01),but there was no significant difference in hs-TnT(P=0.553).The levels of serum copeptin and hs-TnT in AMI patients within 6 h or 12 h after the onset of pain were both higher than those in the normal control(P<0.01).The area under ROC curve of copeptin in diagnosis of AMI was better than hs-TnT(0.900 vs 0.854,P<0.01).During the follow-up of 12 months,8 cases occurred MACE in AMI group,whose copeptin levels within 24 h after the onset of chest pain was significantly higher than those without MACE(P<0.01). Conclusion:Copeptin has a good sensitivity in the early diagnosis of AMI,and it can be used to assess the prognosis of AMI.Copeptin continuous rise indicates poor prognosis.
What problem does this paper attempt to address?